• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

根治性放疗治疗头颈部鳞状细胞癌中上皮细胞黏附分子表达的预后价值。

Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.

机构信息

Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

出版信息

J Radiat Res. 2019 Nov 22;60(6):803-811. doi: 10.1093/jrr/rrz053.

DOI:10.1093/jrr/rrz053
PMID:31361893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6873617/
Abstract

A reliable biomarker can contribute to appropriate treatment selection in the management of head and neck squamous cell carcinoma (HNSCC). Recently, epithelial cell adhesion molecule (EpCAM) was shown to have prognostic features in several malignancies. However, it remains to be elucidated whether EpCAM predicts prognosis of HNSCC after radiotherapy. Therefore, the prognostic potential of EpCAM in HNSCC patients treated by radiotherapy was investigated in this study. All HNSCCs patients examined between January 2013 and December 2015 were analyzed for the expression of EpCAM. One hundred HNSCC patients were identified who were treated by primary radiotherapy. Intense expression of EpCAM was found in 29 HNSCC patients. Two-year overall survival (OS) for patients with intense EpCAM expression was 62.2%, whereas it was 87.9% for those without (P = 0.011). In multivariate analysis, intense EpCAM expression was found to be an independent prognostic factors for OS (P = 0.036). Overall, EpCAM was found to be an independent prognostic factor for HNSCC.

摘要

可靠的生物标志物有助于对头颈部鳞状细胞癌（HNSCC）的治疗选择进行适当的管理。最近，上皮细胞黏附分子（EpCAM）在几种恶性肿瘤中表现出了预后特征。然而，EpCAM 是否能预测 HNSCC 患者放疗后的预后仍有待阐明。因此，本研究旨在探讨 EpCAM 对接受放疗的 HNSCC 患者的预后预测潜力。分析了 2013 年 1 月至 2015 年 12 月期间所有接受检查的 HNSCC 患者的 EpCAM 表达情况。确定了 100 名接受原发性放疗的 HNSCC 患者。在 29 名 HNSCC 患者中发现 EpCAM 表达强烈。EpCAM 表达强烈的患者 2 年总生存率（OS）为 62.2%，而 EpCAM 表达不强烈的患者为 87.9%（P=0.011）。多因素分析显示，EpCAM 表达强烈是 OS 的独立预后因素（P=0.036）。总的来说，EpCAM 是 HNSCC 的一个独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7aa/6873617/00c374101c73/rrz053f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7aa/6873617/68de863a83d5/rrz053f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7aa/6873617/00c374101c73/rrz053f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7aa/6873617/68de863a83d5/rrz053f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7aa/6873617/00c374101c73/rrz053f02.jpg

相似文献

1
Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.根治性放疗治疗头颈部鳞状细胞癌中上皮细胞黏附分子表达的预后价值。
J Radiat Res. 2019 Nov 22;60(6):803-811. doi: 10.1093/jrr/rrz053.
2
Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.EpCAM表达与放射治疗的早期声门癌预后
Laryngoscope. 2014 Nov;124(11):E431-6. doi: 10.1002/lary.24839. Epub 2014 Jul 14.
3
Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.EpCAM 和 slug 表达的数字评分可作为头颈部鳞状细胞癌的预后标志物。
Mol Oncol. 2021 Apr;15(4):1040-1053. doi: 10.1002/1878-0261.12886. Epub 2020 Dec 29.
4
Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.头颈部鳞状细胞癌的化疗耐药性是由 IL-6/p62 相关 Nrf2 抗氧化途径激活诱导的 EpCAM 表达介导的。
Cell Death Dis. 2020 Aug 20;11(8):663. doi: 10.1038/s41419-020-02907-x.
5
Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?老年头颈部癌症患者的放射治疗：标准治疗在老年人中的价值如何？
Radiat Oncol. 2020 Feb 4;15(1):31. doi: 10.1186/s13014-020-1481-z.
6
The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.CDKN2A启动子甲基化在头颈部鳞状细胞癌中的相关性及临床意义：一项Meta分析
Cell Physiol Biochem. 2018;50(3):868-882. doi: 10.1159/000494473. Epub 2018 Oct 24.
7
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).一个由四个 16q24.3 基因组成的与放射（化疗）治疗头颈部鳞状细胞癌（HNSCC）相关的预后 mRNA 表达特征。
Mol Oncol. 2018 Dec;12(12):2085-2101. doi: 10.1002/1878-0261.12388. Epub 2018 Oct 26.
8
Expression of the Epithelial Cell Adhesion Molecule and Cytokeratin 8 in Head and Neck Squamous Cell Cancer: A Comparative Study.
Anticancer Res. 2015 Jul;35(7):3953-60.
9
Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer.声门型 T1-2N0M0 期癌中上皮细胞黏附分子的预后价值
Laryngoscope. 2021 Jul;131(7):1522-1527. doi: 10.1002/lary.29348. Epub 2020 Dec 28.
10
Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.p16表达、淋巴结状态及吸烟对头颈部原发灶不明鳞状细胞癌患者肿瘤学预后的影响
Head Neck. 2016 Sep;38(9):1347-53. doi: 10.1002/hed.24441. Epub 2016 Mar 22.

引用本文的文献

1
Circulating Tumor Cells in Head and Neck Squamous-Cell Carcinoma Exhibit Distinct Properties Based on Targeted Epithelial-Related Markers.头颈部鳞状细胞癌中的循环肿瘤细胞基于靶向上皮相关标志物表现出不同特性。
Curr Issues Mol Biol. 2025 Mar 29;47(4):240. doi: 10.3390/cimb47040240.
2
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors.上皮细胞粘附分子（EpCAM）在人类肿瘤中的表达：与14832例肿瘤中的全细胞角蛋白和TROP2的比较
Diagnostics (Basel). 2024 May 17;14(10):1044. doi: 10.3390/diagnostics14101044.
3
Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma.

本文引用的文献

1
Higher expression of EpCAM is associated with poor clinical and pathological responses in breast cancer patients undergoing neoadjuvant chemotherapy.上皮细胞黏附分子（EpCAM）的高表达与接受新辅助化疗的乳腺癌患者不良的临床和病理反应相关。
Pathol Int. 2016 Apr;66(4):210-7. doi: 10.1111/pin.12404.
2
Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.上皮细胞黏附分子（EpCAM）在口腔鳞状细胞癌中的表达。
Histopathology. 2016 May;68(6):897-904. doi: 10.1111/his.12870. Epub 2015 Nov 16.
3
Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab.
综合分析揭示了上皮细胞黏附分子（EpCAM）在肾透明细胞癌中的双重生物学功能作用。
Heliyon. 2023 Dec 14;10(1):e23505. doi: 10.1016/j.heliyon.2023.e23505. eCollection 2024 Jan 15.
4
Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis.上皮细胞粘附分子在实体瘤中的临床病理及预后价值：一项荟萃分析
Front Oncol. 2023 Aug 16;13:1242231. doi: 10.3389/fonc.2023.1242231. eCollection 2023.
5
The roles EpCAM plays to enhance the malignancy of gastric cancer.上皮细胞黏附分子（EpCAM）在增强胃癌恶性程度方面所扮演的角色。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8495-8505. doi: 10.1007/s00432-023-04767-2. Epub 2023 Apr 24.
6
EpCAM (MOC-31) - immunohistochemical expression in papillary thyroid carcinoma and non invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).EpCAM（MOC-31）在甲状腺乳头状癌和具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤（NIFTP）中的免疫组化表达。
Tunis Med. 2021;99(11):1066-1071.
7
EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer.上皮细胞粘附分子介导的细胞可塑性促进乳腺癌的辐射抗性和转移。
Front Cell Dev Biol. 2021 Jan 6;8:597673. doi: 10.3389/fcell.2020.597673. eCollection 2020.
8
Current View on EpCAM Structural Biology.当前对 EpCAM 结构生物学的认识。
Cells. 2020 May 31;9(6):1361. doi: 10.3390/cells9061361.
9
Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patients.明确放疗治疗鼻咽癌患者的免疫组织病理学特征的预后影响。
J Radiat Res. 2020 Jan 23;61(1):161-168. doi: 10.1093/jrr/rrz071.
局部晚期头颈部鳞状细胞癌患者接受同步放化疗和西妥昔单抗治疗后出现严重胃肠道出血。
J Cancer Res Clin Oncol. 2015 Jan;141(1):177-84. doi: 10.1007/s00432-014-1801-5. Epub 2014 Aug 15.
4
Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.EpCAM表达与放射治疗的早期声门癌预后
Laryngoscope. 2014 Nov;124(11):E431-6. doi: 10.1002/lary.24839. Epub 2014 Jul 14.
5
Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).比较接受手术切除后放疗的宫颈癌患者中腺癌和腺鳞癌的临床结局：一项多中心回顾性研究（KROG 13-10）。
Gynecol Oncol. 2014 Mar;132(3):618-23. doi: 10.1016/j.ygyno.2014.01.043. Epub 2014 Jan 31.
6
Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials.在头颈部随机 DAHANCA 5 和 7 试验中，评估 EGFR 和 HPV 相关 p16 在口咽癌中的表达：与放疗后预后的相关性及其影响。
Radiother Oncol. 2013 Sep;108(3):489-94. doi: 10.1016/j.radonc.2013.08.036. Epub 2013 Sep 20.
7
p53 mutations in cancer.癌症中的 p53 突变。
Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
8
Expression of cell adhesion molecules and prognosis in breast cancer.细胞黏附分子的表达与乳腺癌的预后。
Br J Surg. 2013 Jan;100(2):252-60. doi: 10.1002/bjs.8980. Epub 2012 Nov 22.
9
Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.评估人乳头瘤病毒诊断检测在口咽鳞状细胞癌中的应用：敏感性、特异性和预后判别。
Clin Cancer Res. 2011 Oct 1;17(19):6262-71. doi: 10.1158/1078-0432.CCR-11-0388.
10
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.BRAF V600E 突变型黑色素瘤患者采用威罗菲尼治疗后生存改善。
N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.